Walbert Timothy P — SEC Form 4 filings
SEC reporting owner CIK 1349376. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-04-03 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Director | 4 | — | — | 10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | Director | 3 | — | — | 3 |
| Sagimet Biosciences Inc. (SGMT) | Director | 3 | — | — | 3 |
| Century Therapeutics, Inc. (IPSC) | Director | 2 | — | — | 2 |
| Kardigan, Inc. (KARD) | Director | 1 | — | — | 2 |
| Odyssey Therapeutics, Inc. (ODTX) | Director | 1 | — | — | 1 |
Form 4 filings — Walbert Timothy P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Kardigan, Inc. (KARD) | Grant/award (A): 20,706 @ $0 · Grant/award (A): 57,573 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 3,772 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 3,977 · Option exercise (M): 3,977 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Odyssey Therapeutics, Inc. (ODTX) | Grant/award (A): 27,393 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 32,250 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,703 · Option exercise (M): 5,703 (derivative) @ $0 · Grant/award (A): 6,268 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-02-26 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 3,130 @ $0 | EDGAR |
| 2024-06-21 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 9,279 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 8,779 (derivative) @ $0 · Grant/award (A): 5,703 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 73,014 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1349376 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →